Attribute | Sources examined (#) |
---|---|
Publication (year)a | 54 |
 • <  2012 | • 7 |
 • ≥ 2012 | • 45 |
 • No yearb | • 2 |
Definition of ELL | 54 |
 • ≤ 3 μg/dL | • 1 |
 • ≤ 5 μg/dL | • 43 |
 • ≤ 10 μg/dL | • 10 |
Screeningc | 54 |
 • Targeted | • 35 |
 • Universal | • 18 |
 • Not Addressed | • 1 |
Reporting (for states and District of Columbia only) | 51 |
 • Mandated All Results | • 43 |
 • Mandated ELL Only | • 7 |
 • Undefined | • 1 |
Clinical Management | 54 |
 • Provides Management Guidance | • 43 |
 • No Management Guidance | • 11 |
Follow Up | 54 |
 • Provides Follow Up Guidance | • 40 |
 • No Follow Up Guidance | • 14 |